for May 2018
"The effects of climate are increasingly being recognized in a variety of infectious diseases, but so far as we know this is the first time it has been implicated in the distribution of antibiotic resistance over geographies,"#ActOnClimate #ClimateChange https://t.co/s4RzUJyZiD
— Paul Dawson (@PaulEDawson) May 26, 2018
Important paper: antibiotic resistance genes expressed at higher levels in human infection than in vitro, potentially explaining why assays in the clinical laboratory underestimate resistance in patients https://t.co/Ky8wb0SWyz
— Laura Piddock (@LauraPiddock) May 16, 2018
There’s no “I” in Stewardship!
— Emily Heil (@emilylheil) May 15, 2018
(ok, well there is but successful antimicrobial stewardship programs are all about the team). @SIDPharm @accpinfdprn https://t.co/hJ6nFE4cAm
A new 💥 meta-analysis in @BSACandJAC :No differences between carbapenems and other antibiotics namely Quinolones, aminoglycosides and BL/BLIs for treatment of ESBL-producing Enterobacteriaceae bacteraemia. @MerinoTrial
— Antibiotic Steward (@ABsteward) May 25, 2018
https://t.co/cfqaP5VxFJ pic.twitter.com/iYmQH8cagV
Why oxacillin/nafcillin might sometimes be more effective than cefazolin for staph bacteremia. Any RCTs coming? (Doubtful.) Could initial Rx with ox/naf (more potent) with transition to cefazolin (safer) be the best strategy? https://t.co/EtNMdlzZVy
— Paul Sax (@PaulSaxMD) May 25, 2018
Macrolide resistance in CAP in the ED. "Macrolide resistance is now above 25% in all regions of the United States..." Highlights the need for #antimicrobialstewardship https://t.co/8aeOZlp06g @SIDPharm
— ASHP Emergency Care (@ASHP_EMPharm) May 28, 2018
A new 💥qualitative study of the Real World Experiences of ID Fellows in OFID :Pharmacists, not ID physician leaders, were identified as fellow's 1ry resource for antibiotic teaching. Several fellows suggested ASP should be led by #pharmacists https://t.co/pflc5jLbd4 pic.twitter.com/hvSWCu0mOq
— Antibiotic Steward (@ABsteward) May 4, 2018
Leveraging #antimicrobialstewardship in the emergency department to improve the quality of urinary tract infection management and outcomeshttps://t.co/pu4HL0f3uB
— Brad Langford (@BRxAD) May 5, 2018
Editorial in June @LancetGH "No one likes a parachute researcher: the one who drops into a country, makes use of the local infrastructure, personnel, and patients, and then goes home and writes an academic paper for a prestigious journal." https://t.co/p7s44FLeta
— The Lancet Infectious Diseases (@TheLancetInfDis) May 15, 2018
Meta-analysis in J Hosp Med finds no diff in outcomes for hospitalized pts treated with long v short Abx courses. Article at https://t.co/vc9922ly9A, and my accompanying editorial at https://t.co/QdxUgIouhF
— Brad Spellberg (@BradSpellberg) May 10, 2018
Funding fights antibiotic resistance in nursing homes: telehealth intervention for antibiotic stewardships https://t.co/e12VddoCdy via @uq_news
— David Paterson (@davidantibiotic) May 17, 2018
A retrospective cohort study of 71 MSSA👾 bacteremia pts found more treatment failure with ceftriaxone compared to cefazolin.https://t.co/i9DQHLidYa@IDSAInfo @ESCMID @PaulSaxMD @BradSpellberg @SIDPharm @accpinfdprn @InfectiousDz @BRxAD @ASPphysician @BSACandJAC @Guru_JoshD
— Antibiotic Tweets (@khalideljaaly) May 18, 2018
Bacteria were once thought to be lonely, independent unicellular organisms. This, of course, was a gross oversimplification. Bacteria aggregate to form multicellular communities that behave as a single organism & cooperate to keep this "self" alive. https://t.co/n7PNL80u90
— ASM (@ASMicrobiology) May 31, 2018
A new study in OFID showed Ceftriaxone had a higher rate of treatment failure than cefazolin for the treatment of MSSA bacteremia in a Tertiary Care VA Medical Center. https://t.co/6swRvFCxoP pic.twitter.com/z2Kt0IDXeR
— Antibiotic Steward (@ABsteward) May 18, 2018
Interested in #AntimicrobialResistance - #antimicrobialstewardship? New UNSW Sydney Scientia PhD Scholarship to study w us. Scholarship incl. $40k/year tax free stipend + tuition fees covered for four years + $10k/year for career development. https://t.co/36xQ7W1Py7 @CSRH_UNSW
— Alex Broom (@BroomAlex) May 29, 2018
"Major findings underscore the need for intensified antimicrobial stewardship efforts in NICUs" New #openaccess study in @JAMANetworkOpen of antibiotic use in premature infants: https://t.co/ic5hgDzJCw
— Eli Perencevich 😷 (@eliowa) May 25, 2018
and invited commentary: https://t.co/aKgoirRjeO
#WeWontRest until we can have an impact on slowing down the rise in infections resistant to antibiotics, with our commitment to develop new therapeutics to fight infectious diseases and to continue supporting antimicrobial stewardship #AMR https://t.co/3UM5HeSpPL @MSDInvents pic.twitter.com/uNmepzLo1b
— EFPIA (@EFPIA) May 17, 2018
More evidence for using direct oral challenges to confirm penicillin tolerance.
— Eric Macy (@EricMacyMD) May 30, 2018
Safety and Outcomes of Oral Graded Challenges to Amoxicillin without Prior Skin Testing. - PubMed - NCBI https://t.co/nE08wWFjtX
Have questions about managing infections complicated by secondary bacteremias? The latest “Top Questions in ID” review in OFID addresses oral antibiotics, therapy duration, and repeat blood cultures. https://t.co/yrCU0Jg661 @PaulSaxMD #OpenForumInfectDis pic.twitter.com/NePSQafKkz
— IDSA (@IDSAInfo) May 16, 2018
New #AACJournal minireview: Bacterial adaptation to antibiotics through regulatory RNAs https://t.co/CM8tdLWA6w pic.twitter.com/tmauags9pI
— ASM (@ASMicrobiology) May 9, 2018
Report on our work to protect carbapenems is finally published @SAPGAbx @SIPBS_Strath @AntibioticScot @raseaton66 @AndreaLynPatton https://t.co/Ip4qHccFWg
— jacqui sneddon (@jacquisneddons) May 24, 2018
FDA Advisory Committee Votes Unanimously in Favor of Plazomicin for Adults with cUTIs however the panel does not back BSI indication @IDstewardship@SIDPharm @KisgenUF @BradSpellberg @padstamundohttps://t.co/mAlRNyuicC
— Antibiotic Steward (@ABsteward) May 2, 2018
New @IDstewardship 💥MRSA Nasal Colonization Screening As An Antimicrobial Stewardship Tool For Tailoring Pneumonia Therapy. An interview with @TimbrookTT @AMSPharmD @SIDPharm @accpinfdprn @KisgenUF @ErinMcCreary https://t.co/A4k7ggeWBr
— Antibiotic Steward (@ABsteward) May 5, 2018
“A new review has evidence from 26 trials with more than 75,000 participants, that the #HumanPapillomavirus vaccine protects against #CervicalPrecancer lesions w/out serious adverse effects," says pediatrician Dr. Robert Jacobson. https://t.co/8bBQuMtaXf pic.twitter.com/VWLbBldmBM
— Mayo Clinic (@MayoClinic) May 14, 2018
Rapid Molecular Detection of Gastrointestinal Pathogens and Its Role in Antimicrobial Stewardship. "using [molecular gastrointestinal pathogen test] in clinical practice significantly decreased the inappropriate use of antibiotics" https://t.co/deFdmBvwlA @ASMicrobiology pic.twitter.com/Djmc19EJ5M
— JClinMicro EIC (@JClinMicro) May 14, 2018
Drum roll please! The moment you’ve been waiting for – congrats to our 2018 #AgarArt main contest winners! And thank you to our judges and FB voters. @agruni @FollowNibmg@NEBiolabs @IBR_CONICET #SciArt #BioArt #Microbiology #ASMOutreach #ASMicrobe https://t.co/T2e9FJ0YyH pic.twitter.com/IeZuLQAFh5
— ASM (@ASMicrobiology) May 23, 2018
~150,000 ED visits per year for #antibiotic 😳😣 adverse reaction in this new study, most commonly sulfas, penicillins, fluoroquinolones. 📲 https://t.co/6kXU8yRCbI via @cdcgov @CDC_NCEZID #NotHarmless #UseOnlyWhenNeeded pic.twitter.com/92Ilh2CNkA
— Tim Gauthier (@IDstewardship) May 24, 2018
Bacteria or yeast? Vote for the 2018 #AgarArt People's Choice winner by 'like'-ing your favorite over at https://t.co/rXPgR2Vbe0. #ASMOutreach #scienceisfun #bioart #art #microbiology pic.twitter.com/x8xooOsjbE
— ASM (@ASMicrobiology) May 13, 2018
“A new review has evidence from 26 trials with more than 75,000 participants, that the #HumanPapillomavirus vaccine protects against #CervicalPrecancer lesions w/out serious adverse effects," says pediatrician Dr. Robert Jacobson. https://t.co/OOmIFqqpiX pic.twitter.com/CDJBHwrLpq
— Mayo Clinic (@MayoClinic) May 22, 2018
“The cornerstone of antibiotic stewardship is making an accurate diagnosis.” @Medscape https://t.co/pOj2MmN7aN
— IDSA (@IDSAInfo) May 2, 2018
NEW article out on minimum acceptable susceptibility of empirical antibiotic regimens for Gram Negative BSI with @SIDPharm members @julie_justo & @BBookstaver_USC https://t.co/U0bX0XxW40 pic.twitter.com/x65FAk4v22
— SIDP (@SIDPharm) May 14, 2018
'Effects of primary care #AntimicrobialStewardship outreach on antibiotic use by general practice staff' #JACnews https://t.co/LrQuYqo9La
— BSAC (@BSACandJAC) May 30, 2018
Great @Contagion_Live interview with @JulieSzymczak on the non-cognitive drivers of antibiotic use. If you don’t follow her research, give it a whirl- you’ll be intrigued by what you see. #Antimicrobialstewardship @SIDPharm @accpinfdprn https://t.co/KL2obo2Tbr
— Jason Gallagher (@JGPharmD) May 2, 2018
New from @SIDPharm @accpinfdprn and @MAD_ID_ASP Best Care for Patients is Achieved through Multi-disciplinary Stewardship https://t.co/ZPbbI2klig It was a pleasure being part of this paper
— Susan Davis (@IDPharmProf) May 15, 2018
Our second June Editor's choice article is: Role of antimicrobial stewardship programmes in children: a systematic review, free to read here:https://t.co/PgYSjv4vel
— Journal of Hospital Infection (@jhieditor) May 11, 2018
Shows lack of evidence that programmes reduce antibiotic use in PICUs.
#LHSNwebinar series: Catch Enrique Castro speaking on the role of nurses in antimicrobial stewardship programs. Register: https://t.co/HnbofBVdEr #StopSuperBugs! #AntimicrobialResistance #Nursing @castrocloud pic.twitter.com/VntVq2qMx0
— LHSN (@LHSN_wish) May 30, 2018
📄New! 💊🤓
— Tim Gauthier (@IDstewardship) May 17, 2018
ID pharmacist @DHpharmd reflects in his work engaging bedside #nurses in antimicrobial stewardship activities 📲 https://t.co/VNhKzDcvpG #nurse
cc: @canadanurses @NurseJamieLA @AmerNurse2Day @IJHNursing @UCF_Nursing @UofSCNursing @NYUNursing @faunursing @SHEA_Epi pic.twitter.com/Kh9w2uee5k
Today we posted more than 100 new resources to our antimicrobial stewardship, diagnostics, and One Health bibliographies - have a look! https://t.co/XafujY546N
— CIDRAP-ASP (@CIDRAP_ASP) May 11, 2018
The use of beta-lactamase combination agents to treat ESBL-producing isolates has always been somewhat controversial. Results from the new MERINO clinical trial suggest reviving ESBL testing. Read the latest Bugs & Drugs post: https://t.co/oKQJiPHfop #ASMClinMicro
— ASM (@ASMicrobiology) May 17, 2018
Chuffed that I've been shortlisted for the Das Pillay antimicrobial stewardship award and our @LeicsScouts Antibiotic Guardian scheme has also been shortlisted!
— Ryan Hamilton (@DrRyanHamilton) May 16, 2018
Come join me at the conference. Would be good to see some AMS tweeps there :)https://t.co/kysyNz6vQp
The Use of Telemedicine for Penicillin Allergy Skin Testinghttps://t.co/NzN2YPsMK1 via @jacionline #antimicrobialstewardship
— Brad Langford (@BRxAD) May 12, 2018
A new RCT 💥 just published in Infection Control & Hospital Epidemiology :Modified reporting of positive urine cultures resulted in a significant reduction in inappropriate antibiotic treatment without an increase in adverse events. @Sara_E_Boyd
— Antibiotic Steward (@ABsteward) May 29, 2018
https://t.co/g2w4uMN6CS pic.twitter.com/hCwCDEOD8d
#AntimicrobialStewardship recommendations less likely to be followed for patients with GI infection, febrile neutropenia, skin or soft-tissue infections, admitted for 31–90 days, and by physicians with more years of experience https://t.co/VOa4luN5iV
— Brad Langford (@BRxAD) May 28, 2018
Using #probiotics as a prophylaxis for #Clostridium difficile was safe and reduced the risk for infection among hospitalized patients by two-thirds, according to a large meta-analysishttps://t.co/b8t73IuKNP #CDI #probiotic pic.twitter.com/eg9wWWOQgF
— Microbes&Infection (@MicrobesInfect) May 5, 2018
A new CID article suggests Helen Keller, when she was 19 months old in 1882, likely contracted bacterial meningitis, caused by N. meningitidis or H. influenzae, both now vaccine-preventable causes of meningitis, leaving her deaf and blind. https://t.co/ttl6bYP6Lj #ClinInfectDis pic.twitter.com/jq9d4aD9u0
— IDSA (@IDSAInfo) May 10, 2018
Effects of primary care #AntimicrobialStewardship outreach on antibiotic use by general practice staff #inJAC https://t.co/LrQuYqo9La
— BSAC (@BSACandJAC) May 15, 2018
Tandan et al. reporting on risk of toxicity of FQs.
— Travis King (@s_travis_king) May 22, 2018
"The odds of central nervous system (CNS) and gastrointestinal (GI) related AEs with FQs is nearly three times that of any other antimicrobial." #scary#antimicrobialstewardship @SIDPharm @accpinfdprnhttps://t.co/7HCOcSuan5
In recent years, the J. Antimicrobial Chemotherapy @BSACandJAC has published a vast amount of high calibre research on the topic of antimicrobial stewardship. #JACNews #UKCPAPINJC https://t.co/8hOFOW8x0U pic.twitter.com/dCLrPj8dH2
— Diane Ashiru, PhD (@DrDianeAshiru) May 29, 2018
In Tanzania, where antibiotics can easily be bought without a prescription, pharmacies are pioneering a new way to #StopSuperbugs. You can find out more about their efforts to reduce AMR as well as other global innovators here: https://t.co/9NHmYX1Ygl pic.twitter.com/1sN86bTou2
— AMR at Wellcome (@Wellcome_AMR) May 30, 2018
Cephalosporins are widely, safely, and appropriately used in individuals with confirmed or unconfirmed penicillin allergy.
— Eric Macy (@EricMacyMD) May 14, 2018
There is no clinically significant immunologically mediated cross-reactivity between cephalosporins and penicillins.https://t.co/eQ79v2XtFG https://t.co/VdJvL5uTdI
Does Procalcitonin add anything to good medical care? Not in this large ED-based RCT in LRTI. Spend wisely and invest in your #AMS team over your expensive biomarkers @SAPGAbx @AntibioticScot https://t.co/hK6BkPa5Da
— andrew seaton (@raseaton66) May 21, 2018
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.